Adragos Pharma is actively pursuing contract manufacturing in the Japanese market. Leveraging ex-Sanofi’s Kawagoe plant (located Kawagoe City, Saitama Prefecture) which they acquired one year ago as their flagship manufacturing site, they are reinvesting on solid dosage manufacturing to serve […]
We are pleased to announce the strengthening of our long-established partnership with Colonis Pharma. This collaboration exemplifies our commitment to innovation and reliability in pharmaceutical product development and supply. Over a decade ago, our company, then known as Lamda Laboratories, […]
Plettenberg / Munich / Halden, 1st March 2024 – The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed the acquisition transaction of Fresenius Kabi production site in Halden, Norway – a leading sterile […]
Read about Adragos’ plans and growth predictions in Kawagoe City, Japan. Adragos aims to make significant investments in the Japanese pharmaceutical contract manufacturing industry, as reported by Nikkei. Find the complete article below! Adragos significantly invests in Japanese Kawagoe’s Plant […]
Plettenberg / Munich / Halden, November 15, 2023 – Prange Group and its affiliate Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for the acquisition of the leading sterile pharmaceutical production site in Halden, Norway. As […]
Munich, Germany / Tokyo, Japan, June 15, 2023 — Adragos Pharma GmbH, a global leader in pharmaceutical manufacturing, announced today that it has completed the divestiture of its subsidiary Toride Pharma K.K., and its associated entity, Toride Asset Trading Co. […]
Get notified on our latest news.
